Shareholder letter

02 Mar 2023 10:16 CET

Oslo, March 2, 2023 - Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the
"Company"), a Nordic-based medtech company focused on developing
and commercializing proprietary and innovative medtech products to the global
market through organic growth and targeted M&A, today publishes a shareholder
letter.

The letter to our shareholders is enclosed to this release.

For further information, please contact:

Rune Nystad, CEO Observe Medical



Mobile: +47 916 24 683



E-mail: rune.nystad@observemedical.com

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets and
sells innovative medtech products for the global market. The Company is
committed to improving patient welfare and patient outcomes, improving clinical
data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales
and commercialization of its broad portfolio of medical technology products,
mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound
care, in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in
Narvik (Norway), Gothenburg (Sweden), Oulu (Finland), and Seattle (the US).
In addition, Observe Medical has a direct sale organization in the Nordics and
a distributor network internationally.

Further information is available at www.observemedical.com

More information:
Access the news on Oslo Bors NewsWeb site

584091_Observe_Medical_Shareholder_letter.pdf